REVIVA PHARMACEUTICALS HOLDI (RVPH) Stock Cash Flow
NASDAQ:RVPH - Nasdaq - US76152G1004 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -28.92M | -29.92M | -39.26M | -24.34M | -8.52M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | -2.95M | -4.54M | 7.28M | 5.01M | -702.20K | |||
| Interest Paid | 25.20K | 18.50K | 30.60K | N/A | 0.00 | |||
| Taxes Paid | 3.80K | 3.40K | 19.80K | 16.50K | 2.40K | |||
| Other non cash items | 1.86M | 912.70K | 3.65M | 371.40K | -1.44M | |||
| OPERATING CASH FLOW | -30.01M | -33.54M | -28.32M | -18.96M | -10.67M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -107.70K | 458.20K | 0.00 | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 23.19M | 33.17M | 7.79M | 31.60M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 23.33M | 23.65M | 33.17M | 7.79M | 31.60M | |||
| CHANGE IN CASH | -6.68M | -9.89M | 4.85M | -11.17M | 20.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.01M | -33.54M | -28.32M | -18.96M | -10.67M | |||
| FREE CASH FLOW | -30.01M | -33.54M | -28.32M | -18.96M | -10.67M | |||
All data in USD